News

Deal Announcements

Cognoptix Secures Series D Venture Capital

Thursday, October 2, 2014 5:30:00 AM PDT | VentureDeal
   Acton, Massachusetts  --  Medical technology company Cognoptix has raised $15 million in its fourth round of venture capital funding.

Cognoptix is developing what it calls an "in-office, drug/device diagnostics system as an aid in the early detection of Alzheimer's Disease."

Alopexx led the round, which also included Inventages Venture Capital and Launchpad Venture Group.

The company said it would use the proceeds to fund the pivotal trial and final stages of product development for its diagnostic system.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1